Financial writer analysis of Arcutis Biotherapeutics, Inc. stock surge and potential growth, FDA approvals, and partnerships ...

As Sandoz gears up to launch one of the most anticipated biosimilars of the year, the company could face near-term ...

What’s in and out for skin in 2025? Leading dermatologists share what’s trending in skin care this year, plus their most-recommended products to try.

We asked a dermatologist to weigh in on the best moisturizing hacks for every skin type during winter. She suggested products ...

From pimple patches to gentle micellar cleansers and more, board-certified dermatologist Dr. Dendy Engelman joins TODAY's ...

Amgen Inc. (NASDAQ:AMGN) is a biotechnology powerhouse with an excellent track-record on developing and commercialising products targeting four main therapeutic areas: general medicine ...

Plant extracts within skin products had beneficial effects on some aspects of skin aging, though other aspects had insufficient evidence of benefit.

Amgen’s Lumakras and AstraZeneca’s Calquence are both in line to expand their respective oncology reaches with new FDA approvals. Calquence, in combination with chemotherapy bendamustine and ...

Jan 16 (Reuters) - The U.S. Food and Drug Administration approved Amgen's (AMGN.O), opens new tab combination therapy on Thursday to treat colorectal cancer in patients with a specific gene mutation.

Tatcha skin care loads its products with superfoods, amino acids and a proprietary blend of alpha-hydroxy acids from green tea, algae and twice-fermented rice.

An official ribbon-cutting ceremony took place Friday for Amgen's new manufacturing plant in Holly Springs. It's at the CaMP Helix Innovation Park. The celebration also included a ground-breaking ...